PIH16 COST-EFFECTIVENESS OF DESVENLAFAXINE FOR THE TREATMENT OF VASOMOTOR SYMPTOMS IN BREAST CANCER PATIENTS IN MEXICO
May 1, 2011, 00:00 AM
10.1016/j.jval.2011.02.601
https://www.valueinhealthjournal.com/article/S1098-3015(11)00740-6/fulltext
Section Title :
Disease-Specific Studies
Section Order :
58
First Page :
A108
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00740-6&doi=10.1016/j.jval.2011.02.601